|
|
||||||||
1 From the Department of Ophthalmology, University of Manchester; and 2 Department of Organisational Health Psychology, University of Manchester Institute of Science & Technology, Manchester, United Kingdom.
| Abstract |
|---|
|
|
|---|
METHODS. Frequency-of-seeing (FOS) data were collected from four visual field locations in one eye of 71 subjects (12 ON, 25 POAG, 11 OHT, and 23 normal), using a constant stimulus method on an Henson 4000 perimeter (Tinsley Instruments, Croydon, UK). At each location, at least 20 stimuli (subtending 0.5°) were presented for 200 ms at six or more intensities above and below the estimated threshold. The mean and SD of the probit fitted cumulative Normal function were used to estimate sensitivity and response variability. Cluster regression analysis was carried out to determine whether there were differences in the sensitivity-log (variability) relationship between the four groups.
RESULTS. Variability was found to increase with decreased sensitivity for all four groups. The combined data from the four groups was well represented (R2 = 0.57) by the function loge(SD) = A·sensitivity (dB) + B, where the constants A and B were -0.081 (SE, ±0.005) and 3.27 (SE, ±0.15), respectively. Including other statistically significant covariates (false-negative errors, P = 0.004) and factors (diagnosis, P = 0.005) into the model increased the proportion of explained variance to 62% (R2 = 0.62). Stimulus eccentricity (P = 0.34), patient age (P = 0.33), fixation loss rate (P = 0.10), and false-positive rate (P = 0.66) did not reach statistical significance as additional predictors of response variability.
CONCLUSIONS. The relationship between response variability and sensitivity is similar for ON, POAG, OHT, and normal eyes. These results provide supporting evidence for the hypothesis that response variability is dependent on functional ganglion cell density.
| Introduction |
|---|
|
|
|---|
An increase in visual field variability also occurs in primary open angle glaucoma (POAG).5 6 7 8 9 10 11 Using FOS techniques, applied to single locations within the visual field, it has been established that variability increases as the sensitivity reduces.12 13 14 15 Weber and Rau12 also investigated the relationship between sensitivity and variability in ocular hypertensive (OHT) and normal eyes. They found that peripheral locations in the visual field of OHT and normal eyes, where sensitivity is lower, demonstrated more variability.
Variability in the visual field of POAG eyes decreases with increasing stimulus size.16 17 18 19 20 21 22 This relationship has led to a hypothesis linking variability to functioning ganglion cell density.22 23 The hypothesis is based on three assumptions: (1) that individual ganglion cells give variable responses when repeatedly stimulated, (2) that adjacent ganglion cells do not vary in synchrony with each other, and (3) that there is pooling of responses from ganglion cells. The hypothesis predicts that variability increases when the number of stimulated ganglion cells is reduced, either by reduction of stimulus size or by a reduction in the density of ganglion cells.
According to this hypothesis the variability versus sensitivity relationship would be independent of the underlying cause of any ganglion cell loss. The variability versus sensitivity relationship, therefore, would be similar in POAG and ON despite the significant differences in the mechanism of nerve fiber damage and the nature (depth, location, and permanency) of the visual field defects.
The aim of this study was to establish whether there are differences in the relationship between sensitivity and response variability in ON, POAG, OHT, and normal eyes and which other variables could be clinically important predictors of response variability.
| Methods |
|---|
|
|
|---|
The ON, POAG, and OHT patients were recruited from the outpatient
clinics at the Manchester Royal Eye Hospital. The ON patients all had
defective color vision (Ishihara), reduced visual acuity (VA;
6/9,
equivalent to 0.18 logMAR) and a relative afferent pupillary defect.
Nine patients had a history of numbness. Data were collected from these
patients once their VA had returned to 6/18 or better. The interval
between diagnosis and data collection ranged from 1 to 169 weeks
(median, 26 weeks). The POAG patients all had glaucomatous visual field
loss (AGIS score: range, 1 to 19; median, 5) combined with either (or
both) glaucomatous changes the optic nerve head or a raised intraocular
pressure (IOP; >21 mm Hg). OHT patients all had IOPs greater than 21
mm Hg on two separate occasions, with normal disc appearance and no
visual field loss using program 24-2 and the Glaucoma Hemifield Test of
the Humphrey Visual Field Analyzer (HFA; Humphrey Instruments Inc., San
Leandro, CA).
Normal subjects were recruited from hospital staff and had no history of ophthalmic disease, a normal ophthalmic examination, no systemic illness, and a visual acuity better than 6/9 (equivalent to 0.18 logMAR). The study was approved by the Central Manchester Research Ethics Committee and follows the tenets of the Declaration of Helsinki. Informed consent was obtained from each subject. All subjects underwent a visual field test (HFA 24-2) before the collection of FOS data. They were only included in the study if they fulfilled the HFA reliability criteria (<20% fixation losses, <33% false-positive errors, <33% false-negative errors).
Test Locations
FOS data were collected at four visual field locations during a
single experimental session. For the normal and OHT eyes, the locations
were 12.7° from fixation along the 45, 135, 225, and 315 meridians.
For the ON and POAG eyes, one location was chosen to lie in an area
where sensitivity was within normal limits and, if possible, three
locations in or adjacent to a damaged area of the visual field. The
damaged locations were chosen on the basis of the HFA visual field
test.
Data Collection
FOS data were collected using a modified program on a Henson 4000
bowl perimeter (Tinsley Instruments, Croydon, UK). Stimuli subtended
0.5° and were presented for 200 msec. After input of the test
locations, the program estimated the sensitivity at each location using
the full threshold (4-2) strategy.24
For each location the
program then selected five intensities that straddled the estimated
threshold in steps of 2 dB. At three occasions during each session the
experimenter, who received continuous feedback on the selected
intensities and current responses, would interrupt the collection of
data and adjust the intensities (minimum step size, 1 dB) and number of
presentations to ensure that (1) the response range approached 0 and
100% seen; (2) data were collected for at least six intensities; and
(3) there were a minimum of 20 presentations at each intensity. While
the adjustments were being made, the subject was allowed a short rest.
The presentation of stimuli was randomized with respect to intensity
and location. A typical session lasted for approximately 30 minutes.
Data Analysis
The FOS data from each test location were imported into the
statistical package for probit regression analysis (SPSS, Chicago,
IL). The mean and SD parameters of the fitted cumulative normal
function were used as estimates of sensitivity and response
variability.
Cluster regression analysis25 was used as observations were independent between patients but not within patients. Suitable adjusted (robust) standard errors were computed using STATA V5 (STATA Corporation, College STN, TX) to determine the following:
A backward elimination procedure was used in which insignificant variables were removed successively from the model in order of significance to identify those factors independently contributing to the variance explained by the model.
| Results |
|---|
|
|
|---|
|
|
|
0.24). Table 2
shows the contributions of the different covariates and the diagnosis
factor to the variance explained by the model.
|
Figure 3 gives the data from each group on separate axes along with the individual regression lines and the regression line fitted to the combined data. This figure highlights the agreement between the fit of the combined data and that of the individual groups.
|
| Discussion |
|---|
|
|
|---|
The relationship between sensitivity and response variability was similar between the four groups of patients. Statistical analysis did not detect differences in the slopes of the sensitivity -log(variability) relationship between the four groups. There was a statistically significant difference in the intercept between the normal, OHT, and ON groups and the POAG group, which showed less variability (18%, P = 0.005). This difference might be explained by the greater perimetric experience of the POAG group.
The pathophysiology of ON is very different from that of POAG. In acute ON there is swelling in the area of demyelination that affects the transmission of impulses along the ganglion cell axons. This can take the form of a total block, an attenuation, or an extended refractory period. In certain fibers there is a breakdown of the myelin sheath and a destruction of the ganglion cell axons, with subsequent proximal and distal degeneration. The process can occur at any location within the optic nerve and frequently involves the fibers that supply the fovea. In comparison, damage to ganglion cell axons in POAG is a slow chronic process that occurs at the optic nerve head and more frequently involves the fibers at the superior and inferior poles. The similarity between the data from all groups suggests that there is a common underlying process linking variability with sensitivity, which is independent of the pathophysiology of the two diseases (POAG and ON). A common feature of these two pathologies is the loss of functional ganglion cell axons.
The results from this study support the hypothesis that a reduction in the number of stimulated functional ganglion cells is likely to lead to decreased sensitivity and a concurrent increase in response variability.22 23 This reduction could come about via a loss of ganglion cells, such as occurs in ON and POAG, or transfer of the stimulus to the peripheral visual field.12 This hypothesis also predicts the reported reduction in variability with an increase in the stimulus size.22
In short wavelength perimetry, blue stimuli are presented on a yellow background. This type of perimetry was designed to isolate a sparse population of ganglion cells and, as a result of this, identify loss at an earlier stage.27 Short wavelength perimetry is associated with an increase in response variability.28 29 30 31 FOS curves for motion stimuli, using a line displacement test, show an increase in response variability with increasing motion threshold.32 An increase in variability with loss in sensitivity also has been reported for frequency-doubling perimetry.23 All these findings are in agreement with the hypothesis relating variability to the density of functioning ganglion cells. Some of the benefits resulting from targeting sparse, vulnerable populations may be lost due to the increased response variability associated with sparse populations.
Reliability parameters (fixation loss rate and false-positive and -negative response rates), which were extracted from the prior HFA 24-2 test, did not substantially increase the variance explained by the model. Although the false-negative response rate (P = 0.004) was a significant additional predictor of variability, when included in the model, the explained variance rose by only 2% (R2 increased from 0.60 to 0.62). The studys inclusion criteria of good patient reliability and the poor precision of estimates of patient reliability33 may account for why these covariates did not have a larger effect on the total variance explained by the model.
In summary, the relationship between visual field sensitivity and response variability is similar in ON, POAG, OHT, and normal subjects. This finding lends support to the hypothesis that variability is dependent on functional ganglion cell density. A similar relationship between sensitivity and response variability may exist for other types of perimetric stimuli. The increased variability makes it difficult to differentiate genuine changes in the visual field from noise and, therefore, has important clinical implications. Targeting sparse populations will only be beneficial if it leads to an increase in the "signal-to-noise" ratio between defect and variability.
| Footnotes |
|---|
Submitted for publication May 21, 1999; revised September 21, 1999; accepted October 5, 1999.
Commercial relationships policy: N.
Corresponding author: David B. Henson, Department of Ophthalmology, University of Manchester, Royal Eye Hospital, Oxford Road, Manchester M13 9WH, UK. david.henson{at}man.ac.uk
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Turpin, D. Jankovic, and A. M. McKendrick Retesting Visual Fields: Utilizing Prior Information to Decrease Test-Retest Variability in Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1627 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Strouthidis, A. Scott, A. C. Viswanathan, D. P. Crabb, and D. F. Garway-Heath Monitoring Glaucomatous Visual Field Progression: The Effect of a Novel Spatial Filter Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 251 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Strouthidis, V. Vinciotti, A. J. Tucker, S. K. Gardiner, D. P. Crabb, and D. F. Garway-Heath Structure and Function in Glaucoma: The Relationship between a Functional Visual Field Map and an Anatomic Retinal Map Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5356 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Verdon-Roe, M. C. Westcott, A. C. Viswanathan, F. W. Fitzke, and D. F. Garway-Heath Exploration of the Psychophysics of a Motion Displacement Hyperacuity Stimulus Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4847 - 4855. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Strouthidis, A. Scott, N. M. Peter, and D. F. Garway-Heath Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2904 - 2910. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Vingrys and A. J. Zele Robust Indices of Clinical Data: Meaningless Means Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4353 - 4357. [Full Text] [PDF] |
||||
![]() |
P. H. Artes, D. M. Hutchison, M. T. Nicolela, R. P. LeBlanc, and B. C. Chauhan Threshold and Variability Properties of Matrix Frequency-Doubling Technology and Standard Automated Perimetry in Glaucoma Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2451 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bjerre, J. R. Grigg, N. R. A. Parry, and D. B. Henson Test-Retest Variability of Multifocal Visual Evoked Potential and SITA Standard Perimetry in Glaucoma Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4035 - 4040. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Turpin, A. M. McKendrick, C. A. Johnson, and A. J. Vingrys Properties of Perimetric Threshold Estimates from Full Threshold, ZEST, and SITA-like Strategies, as Determined by Computer Simulation Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4787 - 4795. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Artes, D. B. Henson, R. Harper, and D. McLeod Multisampling Suprathreshold Perimetry: A Comparison with Conventional Suprathreshold and Full-Threshold Strategies by Computer Simulation Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2582 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
P G D Spry, C A Johnson, A M McKendrick, and A Turpin Measurement error of visual field tests in glaucoma Br. J. Ophthalmol., January 1, 2003; 87(1): 107 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gardiner and D. P. Crabb Examination of Different Pointwise Linear Regression Methods for Determining Visual Field Progression Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1400 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Gardiner and D P Crabb Frequency of testing for detecting visual field progression Br. J. Ophthalmol., May 1, 2002; 86(5): 560 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. D. Spry, C. A. Johnson, A. B. Bates, A. Turpin, and B. C. Chauhan Spatial and Temporal Processing of Threshold Data for Detection of Progressive Glaucomatous Visual Field Loss Arch Ophthalmol, February 1, 2002; 120(2): 173 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Artes, D. McLeod, and D. B. Henson Response Time as a Discriminator between True- and False-Positive Responses in Suprathreshold Perimetry Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 129 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. D. Spry, C. A. Johnson, A. M. McKendrick, and A. Turpin Variability Components of Standard Automated Perimetry and Frequency-Doubling Technology Perimetry Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1404 - 1410. [Abstract] [Full Text] |
||||
![]() |
M. Wall, S. G. Punke, T. L. Stickney, C. F. Brito, K. R. Withrow, and R. H. Kardon SITA Standard in Optic Neuropathies and Hemianopias: A Comparison with Full Threshold Testing Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 528 - 537. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |